Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Novel tachykinin NK1 receptor antagonists divulged in recent Merck & Co. patent

Nov. 26, 2008

Hyperphosphatemia controlled with fermagate in hemodialysis patients

Nov. 21, 2008

Serenity initiates phase II clinical study of intranasal drug for urology indication

Nov. 18, 2008

Nymox reports positive results in 59-week study of NX-1207 for BPS

Nov. 13, 2008

EA-230 lessens kidney damage in porcine peritonitis

Nov. 12, 2008

New treatment options for urological disorders reported in recent patents

Nov. 11, 2008

Amitriptyline beneficial in benign prostatic hyperplasia

Nov. 4, 2008

FDA approves fesoterodine for overactive bladder

Nov. 3, 2008

FDA approves Kringle's IND to initiate phase I trial of recombinant human HGF in ARF

Nov. 3, 2008

Tamsulosin-tolterodine ER combination improves ureteral stent-related urinary symptoms

Nov. 3, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...